This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Toronto East General Hospital Doctor Finishes First In Ontario

Urologist Dr. Rajiv Singal puts words into action in Movember Campaign

TORONTO, Nov. 30, 2012 /CNW/ - With the completion of Movember, the Toronto East General Hospital (TEGH) Foundation has congratulated Dr. Rajiv Singal for his inspirational campaign that saw him finish first in Ontario by raising over $42,000 in support of the fight against prostate cancer.

Dr. Singal, longtime Head of the division of urology and current Lead of the surgical robotics program, demonstrated his leadership in prostate cancer awareness by putting his words into action.  He completed the challenge with his moustache intact and finished second across Canada

"I started Movember this year after a three year hiatus to support our patients and annoy my family," said Dr. Singal.  "Urologists of course treat prostate cancer on a daily basis and often in a very profound way but have never taken the lead on this grassroots initiative."

Under Dr. Singal's leadership, the Hospital has invested significantly into the robotic surgery program that has started to establish TEGH as the training ground for the next generation of robotic surgeons. Thanks to donors and a partnership with Sunnybrook Health Sciences Centre, TEGH's recent acquisition of the revolutionary da Vinci System, aka "The Robot" provides patients with the latest in Minimally Invasive Surgical technology. It enhances an already exceptional program and enables surgeons to dramatically change the experience for prostate cancer patients.

"As the month has progressed I have been overwhelmed by the support and it has reinforced why I think we should lead the way," added Dr. Singal. "If the goal is to promote awareness for both the disease and the clinical programs that we run at our institutions then finishing strongly and hopefully on top will most widely achieve that goal."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs